Core Insights - WINFARM reported a consolidated revenue of €35.7 million in Q4 2025, marking a growth of +9.2% compared to Q4 2024, achieving its seventh consecutive quarter of growth [2][3] - For the full year 2025, WINFARM's revenue reached €146.2 million, an increase of +6.1% from 2024 [3] Revenue Breakdown - **Farming Supplies**: Generated €30.6 million in Q4 2025, up +6.2% from Q4 2024, and €126.9 million for the full year, an increase of +4.4% [4][5] - **Farming Production**: Revenue rose to €4.5 million in Q4 2025, a significant increase of +36.4%, and €16.6 million for the full year, up +19.2% [4][6] - **Other Activities**: Maintained steady revenue of €0.6 million in Q4 2025, with a full-year increase to €2.7 million, up +13.8% [4][5] Growth Drivers - The Agronutrition segment emerged as the largest growth driver, with Q4 revenue increasing by +36.4% and full-year growth of +19.2%, largely driven by strong performance in Asia, which accounted for nearly 40% of the division's revenue with a growth rate of +47.3% [6] - The VITAL market saw a sales increase of +4.5% in 2025, while the EQUIDEOS brand in the equine market grew by +7.9% [7] Strategic Focus - WINFARM confirmed an improvement in EBITDA for 2025 compared to 2024, supported by cost optimization measures and strict investment discipline [9] - The company is focusing on expanding its product offerings and enhancing its market presence, particularly in the Agritech consulting and training services [12]